☰

Xing-Xiang Peng, Ph.D. - Publications

Affiliations: 
2008 St. John's University (New York), School of Pharmacy 
Area:
Oncology
Tree Info Grants Similar researchers PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Peng XX, Tiwari AK, Wu HC, Chen ZS. Overexpression of P-glycoprotein induces acquired resistance to imatinib in chronic myelogenous leukemia cells. Chinese Journal of Cancer. 31: 110-8. PMID 22098951 DOI: 10.5732/Cjc.011.10327  0.637
2011 Peng XX, Shi Z, Tiwari AK, Damaraju VL, Fu L, Cass CE, Ashby CR, Kruh GD, Chen ZS. Up-regulation of P-glycoprotein confers acquired resistance to 6-mercaptopurine in human chronic myeloid leukemia cells. Oncology Letters. 2: 549-556. PMID 22866119 DOI: 10.3892/ol.2011.288  0.589
2011 Shi Z, Tiwari AK, Shukla S, Robey RW, Singh S, Kim IW, Bates SE, Peng X, Abraham I, Ambudkar SV, Talele TT, Fu LW, Chen ZS. Sildenafil reverses ABCB1- and ABCG2-mediated chemotherapeutic drug resistance. Cancer Research. 71: 3029-41. PMID 21402712 DOI: 10.1158/0008-5472.Can-10-3820  0.647
2011 Tiwari AK, Shi Z, Shukla S, Robey RW, Singh S, Kim I, Bates SE, Peng X, Abraham I, Ambudkar SV, Talele TT, Fu L, Chen Z. Abstract 1739: Reversal of ABCB1- and ABCG2-mediated drug resistance by sildenafil Cancer Research. 71: 1739-1739. DOI: 10.1158/1538-7445.Am2011-1739  0.641
2009 Zhou Y, Hopper-Borge E, Shen T, Huang XC, Shi Z, Kuang YH, Furukawa T, Akiyama S, Peng XX, Ashby CR, Chen X, Kruh GD, Chen ZS. Cepharanthine is a potent reversal agent for MRP7(ABCC10)-mediated multidrug resistance. Biochemical Pharmacology. 77: 993-1001. PMID 19150344 DOI: 10.1016/J.Bcp.2008.12.005  0.678
2009 Shi Z, Parmar S, Peng XX, Shen T, Robey RW, Bates SE, Fu LW, Shao Y, Chen YM, Zang F, Chen ZS. The epidermal growth factor tyrosine kinase inhibitor AG1478 and erlotinib reverse ABCG2-mediated drug resistance. Oncology Reports. 21: 483-9. PMID 19148526  0.635
2008 Peng XX, Shi Z, Damaraju VL, Huang XC, Kruh GD, Wu HC, Zhou Y, Tiwari A, Fu L, Cass CE, Chen ZS. Up-regulation of MRP4 and down-regulation of influx transporters in human leukemic cells with acquired resistance to 6-mercaptopurine. Leukemia Research. 32: 799-809. PMID 17996297 DOI: 10.1016/j.leukres.2007.09.015  0.618
2007 Shi Z, Peng XX, Kim IW, Shukla S, Si QS, Robey RW, Bates SE, Shen T, Ashby CR, Fu LW, Ambudkar SV, Chen ZS. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance. Cancer Research. 67: 11012-20. PMID 18006847 DOI: 10.1158/0008-5472.CAN-07-2686  0.658
2007 Shi Z, Jain S, Kim IW, Peng XX, Abraham I, Youssef DT, Fu LW, El Sayed K, Ambudkar SV, Chen ZS. Sipholenol A, a marine-derived sipholane triterpene, potently reverses P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells. Cancer Science. 98: 1373-80. PMID 17640301 DOI: 10.1111/J.1349-7006.2007.00554.X  0.63
Show low-probability matches.